Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas

Michael S Nakazawa1, Ian M Silverman2, Victoria Rimkunas2

  • 1Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

PubMed

Insights

Loss of RNase H2 is common in uterine leiomyosarcoma (U-LMS) and may indicate actionable alterations for DNA damage response (DDR) targeted therapies. RNase H2 immunohistochemistry (IHC) shows promise as a predictive biomarker for U-LMS clinical trials.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Targeting the DNA damage response (DDR) pathway is a promising therapeutic strategy for leiomyosarcoma (LMS).
  • RNase H2, a key member of the DDR pathway, represents a potential therapeutic target in LMS.
  • Loss of RNase H2 function is an actionable alteration for DDR-targeted treatments.

Purpose of the Study:

  • To develop and validate protein- and genomic-based assays to screen for RNase H2 loss in LMS.
  • To determine the prevalence and prognostic significance of RNase H2 deficiency in different subtypes of LMS.
  • To evaluate RNase H2 immunohistochemistry (IHC) as a predictive biomarker for DDR-targeted therapies in U-LMS.

Main Methods:

  • Utilized RNase H2-specific antibody on a pan-tumor tissue microarray (TMA) to assess protein expression across various tumor types, including LMS.
  • Analyzed RNase H2 deficiency in uterine LMS (U-LMS) and soft-tissue LMS (ST-LMS) cohorts.
  • Employed targeted next-generation sequencing (NGS) assay (SNiPDx) to detect biallelic loss of function (HomDels) in RNASEH2B.
  • Correlated RNase H2 protein levels with genomic alterations and clinical outcomes in U-LMS patients.

Main Results:

  • RNase H2 loss was significantly more frequent in LMS (11.5%) compared to other tumors (3.8%).
  • RNase H2 deficiency was confirmed in 21% of U-LMS and 30% of ST-LMS cases.
  • RNASEH2B homozygous deletions (HomDels) were identified in 6% of LMS cases in the TCGA database, with a higher prevalence in U-LMS (15%).
  • Targeted NGS detected RNASEH2B HomDels in 54% of U-LMS cases with RNase H2 loss by IHC.
  • RNase H2 loss or RNASEH2B HomDel status did not significantly impact overall survival in U-LMS patients.
  • RNase H2 IHC demonstrated 76% diagnostic accuracy, 93% sensitivity, and 71% specificity for detecting RNASEH2B HomDels in U-LMS.

Conclusions:

  • RNase H2 deficiency is a prevalent alteration in LMS, particularly in U-LMS.
  • RNase H2 IHC is a sensitive and specific method for detecting RNASEH2B HomDels in U-LMS.
  • RNase H2 IHC shows potential as a predictive biomarker for DDR-targeted clinical trials in U-LMS.
  • Further development of RNase H2 IHC is warranted for biomarker-driven clinical trials in U-LMS.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
22.3K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
37.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.6K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
31.0K